Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.21+0.20 (+9.95%)
Close on Nov 13, 2026Market cap $3.21MP/E –Yield –
Nexentis Technologies enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Nexentis Technologies's enterprise value was -$5.45M on Nov 11, 2026, against $140.62M a year earlier. Over the last 5 years it ranged from -$5.45M to $20.75B, with a median of $3.57B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$5.45M | -107.2% |
| 2025 | Dec 31, 2025 | $75.33M | -97.4% |
| 2024 | Dec 31, 2024 | $2.93B | -17.2% |
| 2023 | Dec 29, 2023 | $3.54B | -19.8% |
| 2022 | Dec 30, 2022 | $4.42B | -69.3% |
| 2021 | Dec 31, 2021 | $14.40B | – |
See a number that looks wrong?